ANALYSIS/OPINION: Food and Drug Administration (FDA) Commissioner Scott Gottlieb recently announced new tobacco-control measures that were, within minutes, greeted with adulation by everyone except, of course, that handful of health practitioners
See Original Article

The difference between the two for accounting outcomes is that a sponsor simply expenses DC contributions, whereas for DB plans the sponsor must
See Original Article

“Bad Blood” chronicles the journey of a medical startup that grew to be valued at about $9 billion only to collapse in disgrace. By. Mohamed A. El-Erian.
See Original Article

Storm surge is forcing more people to put their homes on stilts, leaving few options for the elderly and immobile. By. Christopher Flavelle. December
See Original Article

Keeping with the text-crunching, I used the Bloomberg Terminal's document-search function to pull every mention of the phrase “utility of the future” in
See Original Article